BDNF and early-onset autosomal dominant Alzheimer disease: Several clinical applications of BDNF have been developed, which can treat common neuropsychiatric diseases, such as Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, and so forth [70,71,72,73], and can also be used as a reference indicator for early diagnosis and prognosis of certain tumors [74].